Quote | Vivos Therapeutics Inc. (NASDAQ:VVOS)
Last: | $2.72 |
---|---|
Change Percent: | -1.13% |
Open: | $2.69 |
Close: | $2.72 |
High: | $2.7399 |
Low: | $2.61 |
Volume: | 34,105 |
Last Trade Date Time: | 04/19/2024 03:00:00 am |
News | Vivos Therapeutics Inc. (NASDAQ:VVOS)
Vivos Therapeutics (NASDAQ: VVOS) , a leading medical-device and technology company specializing in the development and commercialization of highly effective proprietary treatments for sleep-related breathing disorders, is spotlighted in a recent Proactive interview. During the interview, Vivos C...
--News Direct-- Vivos Therapeutics CEO Kirk Huntsman joined Steve Darling from Proactive shared significant news regarding the regulatory approval for Medicare reimbursement of their oral medical devices designed for sleep apnea treatment. Huntsman emphasized the unique design of Vivos's ...
Message Board Posts | Vivos Therapeutics Inc. (NASDAQ:VVOS)
Subject | By | Source | When |
---|---|---|---|
Goes to a dollar in pre market, loses | PennyPusher786 | investorshub | 03/02/2023 3:23:11 PM |
Lol closes Red... weak ass CEOs out here | PennyPusher786 | investorshub | 03/01/2023 6:35:10 PM |
Junk | harry crumb | investorshub | 03/01/2023 4:29:12 PM |
Loadin .60 | OffTheGrid | investorshub | 03/01/2023 3:38:33 PM |
Shorts want shares badly, Schwab contacted me again | zdog | investorshub | 01/11/2023 10:46:26 PM |
News, Short Squeeze, Breakout and More Instantly...
Vivos Therapeutics Inc. Company Name:
VVOS Stock Symbol:
NASDAQ Market:
Vivos Therapeutics (NASDAQ: VVOS) , a leading medical-device and technology company specializing in the development and commercialization of highly effective proprietary treatments for sleep-related breathing disorders, is spotlighted in a recent Proactive interview. During the interview, Vivos C...
Vivos Therapeutics, Inc. (NASDAQ:VVOS) shares are trading lower Tuesday. The company filed a prospectus related to the resale of up to 1.73 million...
--News Direct-- Vivos Therapeutics CEO Kirk Huntsman joined Steve Darling from Proactive shared significant news regarding the regulatory approval for Medicare reimbursement of their oral medical devices designed for sleep apnea treatment. Huntsman emphasized the unique design of Vivos's ...